Minimally disruptive surgical products manufacturer NuVasive has launched its ALIF ACR in the US, the device is an anterior column realignment procedure for anterior lumbar interbody fusion.
It is focused on correcting the sagittal plane imbalance that results from advanced degeneration. The product gives surgeons a less invasive approach to achieve the same balance as with traditional techniques.
The hyperlordotic implants developed for the ALIF ACR procedure are reportedly the company’s latest innovative advancement in an effort to improve sagittal plane deformity correction.
The ALIF ACR procedure is an alternative method of treating sagittal imbalance without requiring a posterior osteotomy represents a significant advancement in spinal deformity correction.
Traditional ALIF implants offer only 8° to 15° of lordosis, however the implants developed for the ALIF ACR procedure offer a 20° and 30° hyperlordotic footprints and may improve sagittal balance restoration capabilities.
The innovative product offers surgeons a familiar ALIF technique to increase alignment where 80% of sagittal balance exists, between L4 and S1.
NuVasive Global Products and Services president Pat Miles said influenced by the initial success of XLIFACR, ALIF ACR provides a procedurally integrated solution to restore the natural anterior column, while increasing foraminal height in the lower levels of the lumbar spine.
"Our efforts to address sagittal imbalance with unique techniques demonstrate NuVasive’s continued commitment to changing spine surgery with innovation," Miles said.
The ALIF ACR technique leverages the rich clinical history of anterior lumbar surgical access with an innovative implant design. Anterior approaches, such as ALIF, obtain access to the disc space from the front of the spine.
Advantages to ALIF are significant and include less blood loss, shorter surgical time, and a quicker recovery, according to the company. The procedure is also significantly less painful than traditional correction techniques.
Image: The ALIF ACR procedure offers a 20° and 30° hyperlordotic footprints. Photo: courtesy of NuVasive, Inc.